Clinical Trial Update: Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term effects of a DPP-4 inhibitor in type 2 diabetes mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor (class)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-08-13